NCT00402298 - Randomized Placebo-controlled Study of MDMA-assisted Therapy in People With PTSD - Israel | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 27, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

May 5, 2010

Conditions

Posttraumatic Stress Disorder

Interventions

DRUG

Full Dose Midomafetamine HCl

Participants will receive an initial dose of 125 mg midomafetamine HCl orally followed 2.5 hours later by 62.5 mg midomafetamine HCl orally during the course of a day-long therapy session.

DRUG

Low Dose Midomafetamine HCl

Participants will receive an initial dose of 25 mg midomafetamine HCl orally followed 2.5 hours later by a supplemental dose of 12.5 mg midomafetamine HCl orally during the course of each of two day-long therapy sessions.

Trial Locations (1)

Unknown

Be'er Ya'akov Mental Health Center, Be’er Ya‘aqov